Treatment of gram-negative bacillary meningitis in adults.
D000328:Adult; D000421:Alcaligenes; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001419:Bacteria; D001424:Bacterial Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002509:Cephaloridine / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004754:Enterobacter; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology; D011113:Polymyxins / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012705:Serratia
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D002228:Carbenicillin; D002509:Cephaloridine; D002512:Cephalothin